α-Methylacetylfentanyl
 |
|
| Systematic (IUPAC) name | |
|---|---|
| N-Phenyl-N-[1-(1-phenylpropan-2-yl)-4-piperidyl]acetamide | |
| Clinical data | |
| Legal status | Schedule I (CA) Class A (UK) Schedule I (US) |
| Identifiers | |
| CAS number | 101860-00-8 |
| ATC code | None |
| PubChem | CID 62307 |
| DrugBank | DB01532 |
| ChemSpider | 56102  |
| Synonyms | α-methylacetylfentanyl, acetyl-α-methylfentanyl |
| Chemical data | |
| Formula | C22H28N2O |
| Mol. mass | 336.471 g/mol |
|
|
|
|
 (what is this?) (verify) |
|
α-Methylacetylfentanyl (or alphamethylacetylfentanyl) is an opioid analgesic that is an analog of fentanyl. It is a Schedule I controlled substance in the United States, with a DEA ACSCN of 9815.
α-Methylacetylfentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared.[1] α-Methylacetylfentanyl is made with the same synthetic route as α-methylfentanyl, but by substituting the relatively common acetic anhydride for the more difficult to obtain chemical propionic anhydride in the synthesis.
α-Methylacetylfentanyl has similar effects to fentanyl.[medical citation needed] Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression which can be life-threatenng.
The 2013 DEA production quota for acetyl-alpha-methylfentanyl is 2 grammes. [2]
References[edit]
- ^ Henderson GL (1988). "Designer Drugs: Past History and Future Prospects". Journal of Forensic Sciences 33 (2): 569–575. PMID 3286815.
- ^ http://www.deadiversion.usdoj.gov/fed_regs/quotas/2013/fr0620.htm
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
